No true generic versions are currently available in the United States due to patent protection held by manufacturer Novo Nordisk
With a US presence spanning 40 years, Novo Nordisk US is headquartered in New Jersey and employs over 10,000 people across more than 10 manufacturing, R&D and corporate locations in eight states plus Washington, D.C
PubMed Central, Qi, Qibin, et al
If you are taking both semaglutide and an SGLT-2 inhibitor, which some diabetes management protocols include, the UTI risk from the SGLT-2 component deserves attention
The most successful users treat semaglutide as a tool that makes good dietary habits easier to follow, not as a replacement for them